RN
Rein Therapeutics Inc. (RNTX)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$1.46
-2.01%
Mkt Cap $31.54M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | — | — | — | -$1.09 | -$1.09 | +0.00% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.24 | -$0.21 | +12.50% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.22 | -$0.28 | -27.27% | — | — |
| Q2 2025 Apr 7, 2025 | — | — | — | -$0.14 | -$0.26 | -85.71% | — | — |
| Q4 2024 Dec 31, 2024 | — | — | — | -$0.46 | -$1.89 | -310.68% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.25 | -$0.27 | -8.00% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.25 | -$0.45 | -80.00% | — | — |
| Q1 2024 Mar 31, 2024 | — | — | — | -$0.14 | -$0.86 | -512.00% | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | -$0.16 | -$1.54 | -840.03% | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | -$0.20 | -$0.40 | -101.16% | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | -$0.40 | -$0.39 | +1.62% | — | — |